- Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma
-
Lee WS, Kim DH, Shin SH, Woo SI, Kwan J, Park KS, Park SD, Yi HG, Jeon SH
- KMID: 1106457
- Yonsei Med J.
- 2011 Jan;52(1):196-198.
- doi: 10.3349/ymj.2011.52.1.196
Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here... -
- CITED
-
- Close
- SHARE
-
- Close
